Robert Lamberton BSc FNTP 
A new study offers a possible explanation for why high blood pressure may worsen osteoarthritis in some joints but not others. We look at vasopressin, prior injury and what practitioners can—and can’t—take from the findings.
In the GLP-1 era, practitioners are helping patients lose weight faster and in larger amounts than before. That makes skeletal protection increasingly important. This article examines five signals that change during weight loss—mechanical loading, estrogen, calcium balance, gut delivery, and rate—and translates them into practical considerations for screening and intervention.
The gut is often where complex physiology becomes visible—not necessarily where it begins. Explore a structured laboratory and systems-based approach for identifying upstream drivers and sequencing care in gut-first presentations.
In the case of tech entrepreneur Bryan Johnson, the most expensive, most data-rich health optimization protocol on the planet produced eleven years of an unread signal of autoimmune gastritis because the framework being applied was looking for problems in isolation rather than reading a signal architecture.
Sauna is one of the most evidence-backed lifestyle interventions for cardiovascular and brain health—but its benefits are not automatic. In chronically stressed, depleted patients, the same thermal dose that extends healthspan in Finnish cohorts can act as additional allostatic load.
Glaucoma management focused exclusively on IOP reduction addresses one risk factor while leaving the primary pathological mechanism—RGC apoptosis driven by mitochondrial failure, neuroinflammation, cortisol-mediated trabecular meshwork dysfunction, and autonomic vascular dysregulation—substantially unaddressed.
Systemic lupus erythematosus does not emerge randomly in patients carrying latent EBV. In this Part 2 of our Systems Homeostasis series, we trace how EBNA2-driven B cell reprogramming, the IFN-I amplification loop, and depleted “circuit breakers” such as IL‑10, Tregs, DNase activity, and antioxidant capacity converge to determine disease expression and treatment response. Clinicians gain a practical framework for reading IFN-I signatures and upstream signal environment data long before full diagnostic criteria are met.
This clinical briefing connects recent mechanistic findings on EBV reprogramming of autoreactive B cells to HPA axis–mediated failure of cytotoxic surveillance and enteric immune dysfunction. It outlines measurable upstream markers — diurnal cortisol/DHEA profiles (Fluids-IQ SHP), circadian inversion patterns, and midday enteric melatonin — that can identify patients at elevated risk for EBV-driven autoimmunity and inform earlier, mechanism-targeted interventions.
Clear, systems-based explanation of why cannabis dependence persists after quitting and what staged recovery strategies target the underlying biology.
A clinical systems-signalling approach reframes treatment: assess regulation and capacity first, then sequence interventions to match a patient’s ability to respond.
